These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12633883)

  • 1. Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques.
    Apelt J; Ach K; Schliebs R
    Neurosci Lett; 2003 Mar; 339(3):183-6. PubMed ID: 12633883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
    Bigl M; Apelt J; Eschrich K; Schliebs R
    J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.
    Leissring MA; Farris W; Chang AY; Walsh DM; Wu X; Sun X; Frosch MP; Selkoe DJ
    Neuron; 2003 Dec; 40(6):1087-93. PubMed ID: 14687544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
    Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
    PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.
    Apelt J; Schliebs R
    Brain Res; 2001 Mar; 894(1):21-30. PubMed ID: 11245811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide.
    Yasojima K; Akiyama H; McGeer EG; McGeer PL
    Neurosci Lett; 2001 Jan; 297(2):97-100. PubMed ID: 11121879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
    Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
    Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neprilysin and amyloid beta peptide degradation.
    Hersh LB; Rodgers DW
    Curr Alzheimer Res; 2008 Apr; 5(2):225-31. PubMed ID: 18393807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology.
    Rossner S; Apelt J; Schliebs R; Perez-Polo JR; Bigl V
    J Neurosci Res; 2001 Jun; 64(5):437-46. PubMed ID: 11391698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
    Mehlhorn G; Hollborn M; Schliebs R
    Int J Dev Neurosci; 2000; 18(4-5):423-31. PubMed ID: 10817926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin regulates amyloid Beta peptide levels.
    Marr RA; Guan H; Rockenstein E; Kindy M; Gage FH; Verma I; Masliah E; Hersh LB
    J Mol Neurosci; 2004; 22(1-2):5-11. PubMed ID: 14742905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice.
    Xu CJ; Wang JL; Jing-Pan ; Min-Liao
    Curr Alzheimer Res; 2019; 16(3):219-232. PubMed ID: 30827242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
    Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E
    J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques (APs) of Hsiao's APP-Sw transgenic mouse brains, but absence in APs of Alzheimer's disease brains.
    Wen GY; Yang SY; Kaczmarski W; He XY; Pappas KS
    Brain Res; 2002 Nov; 954(1):115-22. PubMed ID: 12393239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging.
    Iwata N; Takaki Y; Fukami S; Tsubuki S; Saido TC
    J Neurosci Res; 2002 Nov; 70(3):493-500. PubMed ID: 12391610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.